Chinese Journal of Antituberculosis ›› 2025, Vol. 47 ›› Issue (8): 1089-1091.doi: 10.19982/j.issn.1000-6621.20250108
Received:2025-03-17
Online:2025-08-10
Published:2025-08-01
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20250108
| [1] | 中华医学会血液学分会. 慢性髓性白血病中国诊断与治疗指南(2020年版). 中华血液学杂志, 2020, 41(5): 353-364. doi:10.3760/cma.j.issn.0253-2727.2020.05.001. |
| [2] |
Iqbal P, Soliman A, De Sanctis V, et al. Association of tuberculosis in patients with chronic myeloid leukemia: a treatment proposal based on literature review. Expert Rev Hematol, 2021, 14(2): 211-217. doi:10.1080/17474086.2021.1875818.
pmid: 33433245 |
| [3] |
Liu K, Li F, Lu J, et al. Bedaquiline metabolism: enzymes and novel metabolites. Drug Metab Dispos, 2014, 42(5): 863-866. doi:10.1124/dmd.113.056119.
pmid: 24513655 |
| [4] |
Peng B, Lloyd P, Schran H. Clinical pharmacokinetics of imatinib. Clin Pharmacokinet, 2005, 44(9): 879-894. doi:10.2165/00003088-200544090-00001.
pmid: 16122278 |
| [5] |
Gellner K, Eiselt R, Hustert E, et al. Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics, 2001, 11(2):111-121. doi:10.1097/00008571-200103000-00002.
pmid: 11266076 |
| [6] | Bolton AE, Peng B, Hubert M, et al. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects. Cancer Chemother Pharmacol, 2004, 53(2): 102-106. doi:10.1007/s00280-003-0722-9. |
| [7] | Kim Dj, Jeong S, Kong SG, et al. First case report of latent tuberculosis reactivation complicating treatment with nilotinib in chronie myeloid leukemia. Blood Res, 2019, 54(2): 151-153. doi:10.5045/br.2019.54.2.151. |
| [8] | Bhatnagar V, Adelakun A, Kendall T, et al. Diseases at the crossroads: chronic myelogenous leukemia and tuberculosis. Arch Iran Med, 2015, 18(1):65-68. |
| [9] |
Darmayani IGAAPS, Ascobat P, Instiaty I, et al. Bedaquiline Effect on QT Interval of Drugs-Resistant Tuberculosis Patients: Real World Data. Acta Med Indones, 2022, 54(3): 389-396.
pmid: 36156479 |
| [10] | 谢莉, 高静韬, 马丽萍, 等. 含贝达喹啉方案治疗耐多药肺结核对患者心电图QT间期的影响. 中国防痨杂志, 2020, 42(7): 687-694. doi:10.3969/j.issn.1000-6621.2020.07.009. |
| [1] | Fan Jun, Wang Qingya, Wu Chengguo, Lei Rongrong, Zhang Ya, Zhang Ting. Investigation on the psychological and social support status of 445 pulmonary tuberculosis patients in Chongqing metropolitan area [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1007-1013. |
| [2] | Xue Yu, Guo Shubin, Lei Xuan, Zhang Jing, Li Wensheng, Liu Yan, Li Huan, Liu Zhifeng, Wang Wei, Wen Li. Construction and analysis of early warning and prediction model for risk factors of initially treated severe pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1038-1043. |
| [3] | Abuduresuli Tu’ersun, Abudukeyoumujiang Abulizi, Patiman Maimaiti, Huang Chencui, Shen Lingyan, Mayidili Nijiati. Predicting pulmonary tuberculosis treatment outcomes using longitudinal chest CT radiomics and deep learning [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1044-1052. |
| [4] | Kong Hanhan, Chen Zijiao, Zeng Jianfeng, Wu Dan, Tang Lin, Wen Min. Development and reliability and validity testing of the Pulmonary Tuberculosis Symptom Cluster Scale [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1062-1067. |
| [5] | Xia Hui, Zhao Yanlin. The potentials and challenges of using tongue swab for Mycobacterium tuberculosis complex detection through nucleic acid amplification tests in the diagnosis and screening of pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 976-980. |
| [6] | Sun Shanhua, Lezhe Laji, Gao Zhidong, Zhao Yao, He Xin, Xu Qiang, Yang Maosheng, Xu Yan. Knowledge, attitude and practice survey on tuberculosis prevention and control among specific populations in Meigu County, Liangshan Yi Autonomous Prefecture, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 992-998. |
| [7] | Tang Lingling, Chen Danping, Li Yuru, Jiang Hua, Huang Le, Su Limin. Analysis of family functioning of patients with drug-resistant pulmonary tuberculosis and its influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 999-1006. |
| [8] | Zhang Canyou, Xia Yinyin, Chen Hui, Zhao Fei, Wang Lixia, Zhang Hui, Cheng Jun. Community-based active case-finding for pulmonary tuberculosis in the elderly: analysis of strategies and effectiveness based on a multicenter cohort study [J]. Chinese Journal of Antituberculosis, 2025, 47(7): 846-854. |
| [9] | Yang Zeliang, Ma Zichun, Shang Yuanyuan, Shi Jin, Jing Wei, Pang Yu, Qin Lin. The diagnostic value of targeted next generation sequencing in sputum-free pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(7): 878-883. |
| [10] | Wei Liuying, Jing Wei, Liu Zhifeng, Nie Wenjuan, Huang Xianzhen, Huang Lianpiao, Ban Fengting, Lin Yanrong, Yang Shixiong, Zhu Qingdong. Cost-effectiveness analysis of bedaquiline-containing regimens for the treatment of patients with multidrug/rifampicin-resistant pulmonary tuberculosis in Nanning: a retrospective cohort study [J]. Chinese Journal of Antituberculosis, 2025, 47(7): 914-920. |
| [11] | Zhao Yanfeng, Tu Xia, Wang Nenhan, Chen Shuangshuang, Tian Lili, Fan Ruifang, Yu Lan, Li Jie, Li Chuanyou, Dai Xiaowei. Contribution analysis of three diagnostic methods in the etiological detection of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 701-707. |
| [12] | Peng Hua, Cui Junwei, Shang Qiubai, Li Siqing, Peng Ruiqin. Effectiveness of a nursing intervention based on the Transtheoretical Model combined with the Health Belief Model in patients with pulmonary tuberculosis and chronic obstructive pulmonary disease [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 727-731. |
| [13] | Wang Hanfei, Li Jinhao, Wen Yaxin, Xu Caihong. Analysis of diagnosis and treatment delays and influencing factors of rifampicin-resistant tuberculosis patients in China, 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 738-745. |
| [14] | Shi Xiaojing, Guo Jianhua, Wang Xin, Zhao Qingran, Wang Yuhan. A study on the acceptance of preventive treatment and its influencing factors among latent tuberculosis infectors in Shijiazhuang City [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 746-752. |
| [15] | Li Yuhong, Mei Jinzhou, Li Xue, Zhang Hui, Liu Xiaoqiu, Zhao Yanlin. Analysis of the epidemiological characteristics of inter-provincial migrant tuberculosis patients from 2018 to 2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 760-768. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
